SUTESGO 12.5 mg Hard Capsule containing the lively ingredient sunitinib, respectively; It’s categorised as Antineoplastic and Immunomodulatory Brokers, Antineoplastics, Different Antineoplastic Brokers, protein kinase inhibitors and Sunitinib and is among the many licensed medication within the Medicines and Medical Units Company with the ATC code L01XE04. SUTESGO 12,5 mg, which you’ll receive from the pharmacy with a standard prescription, is a product of DEVA HOLDING. Transient info and prospectus paperwork for SUTESGO 12.5 mg (Indications, what’s SUTESGO a drug; what to observe earlier than beginning the drug, SUTESGO dosage; whether or not its use is appropriate for individuals who are breastfeeding or pregnant; interplay, drawbacks; advantages, storage circumstances; SUTESGO utilization; SUTESGO SUTESGO 12.5 mg, reminiscent of unwanted side effects, undesirable-side results and proposals
The submit SUTESGO 12.5 mg Hard Capsule first appeared on İlaç Net.
